A retrospective, observational study of emtricitabine/tenofovir disoproxil fumarate (EVG/c/FTC/TDF) or emtricitabine/tenofovir alafenamide fumarate (EVG/c/FTC/TAF) in the lipid profile of patients with HIV-infections
Latest Information Update: 17 Jul 2019
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 17 Jul 2019 New trial record